SECURITIES PURCHASE AGREEMENT
Exhibit
10.7
4P Management Partners SA
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 1/18/2006,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: 4P Management Partners
SA
Country
of incorporation or
residence: Panama
Signature
of Authorized Signatory of Purchaser:
/s/
X. Xxxxx
Name
of
Authorized Signatory: X. Xxxxx
Title
of
Authorized Signatory: Attorney-in-Fact
Email
Address of Purchaser: xxx@xxxxxx.xx
Address
for notice of Purchaser: c/o
INTERGLOBE
FINANCE SA
General
Xxxxxx-Xxxx 00
XX
0000 XXXXXX
Address
for delivery of Securities for Purchaser (if not same as above):
INTERGLOBE
FINANCE SA
General
Xxxxxx-Xxxx 00
XX
0000 XXXXXX
Subscription
Amount: $25,000
Shares:
50,000 SHS
Warrant
Shares: ________________________________
Date:
December 19, 2005
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 1/18/06,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as
of the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective
and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to
cause
the Registration Statement to be declared effective under the Securities
Act as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required
by the
Commission, the name of the Person who has voting and dispositive control
over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities
or Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of
the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of
the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act
or
(ii) any untrue or alleged untrue statement of a material fact contained
in any
Registration Statement, or arising out of or relating to any omission or
alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is
sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal
or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release
of the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as
a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and
any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a
result
of any Losses is deemed to include, subject to the limitations set out in
this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement,
each
Holder or the Company, as the case may be, in addition to being entitled
to
exercise all rights granted by law and under this Agreement, is entitled
to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its
best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to
the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided
by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in
full
force and effect and are in no way affected, impaired or invalidated, and
the
parties will use their commercially reasonable efforts to find and employ
an
alternative means to achieve the same or substantially the same result as
that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations
of any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association,
a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations
or the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be
joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable
have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration
under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement
under the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and
in
accordance with applicable state securities laws as evidenced by a legal
opinion
of counsel to the transferor to such effect, the substance of which will
be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have
been
issued pursuant to an exemption from registration under the Securities
Act of
1933, as amended, pursuant to regulation S thereunder. This security and
the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term
is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 50,000
shares
of common stock of
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, 4P Management Partners
SA (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and
the
conditions hereinafter set forth, at any time on or after the date given
above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise
Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
50,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal
to the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the
same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
1/18/2006, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at
any time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days
of
delivering the Notice of Exercise to the Company, (A) this Warrant, and
(B) by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the
Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after
the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise
of this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the
Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this
Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d)
of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that
the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible
for any
schedules required to be filed in accordance with it. The determination
of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder,
and the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in
the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder
may
rely on the number of outstanding shares of Common Stock as reflected in
the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of
shares of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of
Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued,
fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise
within 3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount
is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed
to have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to
this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued
upon the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by
the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its
Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to
this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into
a
smaller number of shares, or (iv) issues by reclassification of shares
of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of
shares
of Common Stock (excluding treasury shares, if any) outstanding before
the event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this
Warrant
must be proportionately adjusted by this fraction. Any adjustment made
pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer
by
which holders of Common Stock are permitted to tender or exchange their
shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant to which
the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right
to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company
has
given its other holders of its Common Stock for the conversion of their
Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or
surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by
or for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as
of a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the
record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat
the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights
as a
shareholder of the Company before the Exercise Date. Upon the surrender
of this
Warrant and the payment of the aggregate Exercise Price, the Company will
issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant
or any stock certificate relating to the Warrant Shares, and, in case of
loss,
theft or destruction, of indemnity or security reasonably satisfactory
to it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant
or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve
from
its authorized and unissued Common Stock a sufficient number of shares
to
provide for the issuance of the Warrant Shares upon the exercise of any
purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged
with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as
may be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of
the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action
avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of
all its
terms and take whatever actions is necessary or appropriate to protect
the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of
the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by
state and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder
on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or
delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and
binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or
invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only
and are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant),
and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 8,333
shares
of common stock of
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, 4P Management
Partners (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 8,333
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Xxxxxxx Hochwimmer
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 11/28/2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Xxxxxxx Hochwimmer
Country
of incorporation or residence: Germany
Signature
of Authorized Signatory of Purchaser:
/s/
Xxxxxx Hochwimmer
Name
of
Authorized Signatory: Georg Hochwimmer
Title
of
Authorized Signatory:___________________________________________
Email
Address of Purchaser: xxxxxxxxxx@xxxxxxxxxxxxxxx.xx
Address
for notice of Purchaser: Am Griesberg 19, X-00000,
Xxxxxxxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
______________________________________________________________
______________________________________________________________
Subscription
Amount: $13,500
Shares:
27,000
Warrant
Shares: 27,000
Date:
October 28th, 2005
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 11/28/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable
have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal
opinion
of counsel to the transferor to such effect, the substance of which will
be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have
been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and
the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 27,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxxxx
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given
above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
27,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the
same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
11/28/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after
the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise
of this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d)
of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in
the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder
may
rely on the number of outstanding shares of Common Stock as reflected in
the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of
Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued,
fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount
is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by
the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its
Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to
this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into
a
smaller number of shares, or (iv) issues by reclassification of shares of
the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of
shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this
Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer
by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant to which
the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right
to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company
has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat
the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights
as a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will
issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant
or any stock certificate relating to the Warrant Shares, and, in case of
loss,
theft or destruction, of indemnity or security reasonably satisfactory to
it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or
stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve
from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of
the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action
avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder
on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and
binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or
invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A
TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
WILL BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY
AND THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM
IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE
SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 2,333
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxxxx
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and
the
conditions hereinafter set forth, at any time on or after the date given
above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise
Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold
Corp., a
Nevada corporation (the “Company”),
up
to 2,333
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal
to the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have
the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at
any time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed
facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days
of
delivering the Notice of Exercise to the Company, (A) this Warrant, and
(B) by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the
Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after
the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the
Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise
of this
Warrant, but excludes the number of shares of Common Stock that would
be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the
Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this
Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d)
of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that
the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible
for any
schedules required to be filed in accordance with it. The determination
of
whether this Warrant is exercisable (in relation to other securities
owned by
the Holder and its Affiliates) is in the sole discretion of the Holder,
and the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out
in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder
may
rely on the number of outstanding shares of Common Stock as reflected
in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of
shares of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares
of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued,
fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the
issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise
within 3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount
is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed
to have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the
certificate
or certificates representing Warrant Shares, deliver to Holder a new
Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant
to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued
upon the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied
by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the
Holder and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner
that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of
its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant
to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into
a
smaller number of shares, or (iv) issues by reclassification of shares
of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number
of shares
of Common Stock (excluding treasury shares, if any) outstanding before
the event
and of which the denominator is the number of shares of Common Stock
outstanding
after the event, and the number of shares issuable upon exercise of this
Warrant
must be proportionately adjusted by this fraction. Any adjustment made
pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is
effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the
Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer
by
which holders of Common Stock are permitted to tender or exchange their
shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant to which
the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right
to
receive, for each Warrant Share that would have been issued upon the
exercise
absent the Fundamental Transaction, the same consideration as the Company
has
given its other holders of its Common Stock for the conversion of their
Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or
surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly
adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held
by or for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding
as of a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the
Company
will notify the Holders of the proposal at least twenty days before the
record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat
the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights
as a
shareholder of the Company before the Exercise Date. Upon the surrender
of this
Warrant and the payment of the aggregate Exercise Price, the Company
will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant
or any stock certificate relating to the Warrant Shares, and, in case
of loss,
theft or destruction, of indemnity or security reasonably satisfactory
to it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant
or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday,
Sunday or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve
from
its authorized and unissued Common Stock a sufficient number of shares
to
provide for the issuance of the Warrant Shares upon the exercise of any
purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged
with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase
rights
under this Warrant. The Company will take all such reasonable action
as may be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements
of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action
avoid
or seek to avoid the observance or performance of any of the terms of
this
Warrant, but will at all times in good faith assist in carrying out of
all its
terms and take whatever actions is necessary or appropriate to protect
the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions
of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by
state and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder
on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or
delivered
by either party to the other must be delivered in accordance with the
notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of
and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted
under
applicable law, but if any provision of this Warrant is prohibited by
or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only
and are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant
(only if
exercised in full; if exercised in part, attach a copy of the Warrant),
and
tenders herewith payment of the exercise price in full, together with
all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS
EXERCISABLE HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR
IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED
BY A LEGAL OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF
WHICH WILL BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY
AND THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE
TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS
THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER
THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 6,777
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxxxx
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise
and the
conditions hereinafter set forth, at any time on or after the date
given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial
Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River
Gold Corp., a
Nevada corporation (the “Company”),
up
to 6,777
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant
is equal to the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant
have the same
meanings as they have in the Securities Purchase Agreement (the
“Purchase
Agreement”),
dated 4/29/2005,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant
at any time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed
facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading
Days of
delivering the Notice of Exercise to the Company, (A) this Warrant,
and (B) by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times
the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately
after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares
of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and
its Affiliates
includes the number of shares of Common Stock issuable upon the
exercise of this
Warrant, but excludes the number of shares of Common Stock that
would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities
of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes
of this Section
2(c),
beneficial ownership must be calculated in accordance with Section
13(d) of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder
that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible
for any
schedules required to be filed in accordance with it. The determination
of
whether this Warrant is exercisable (in relation to other securities
owned by
the Holder and its Affiliates) is in the sole discretion of the
Holder, and the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set
out in the
Notice of Exercise and subject to the limitations in this Section
2(c);
and the
Company is not obliged to verify or confirm the accuracy of the
Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the
Holder may
rely on the number of outstanding shares of Common Stock as reflected
in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number
of shares of
Common Stock outstanding, or (C) any other notice by the Company
or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of
shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly
issued, fully
paid and non-assessable, and free from all taxes, liens and charges
(other than
taxes in respect of any transfer occurring contemporaneously with
the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to
the
Holder to the address specified by the Holder in the Notice of
Exercise within 3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise
Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is
deemed to have
become a holder of record of the shares for all purposes, on the
Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers
the certificate
or certificates representing Warrant Shares, deliver to Holder
a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant
Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder
a
certificate or certificates representing the Warrant Shares pursuant
to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be
issued upon the
exercise of this Warrant. If the Holder would otherwise be entitled
to
fractional shares upon the exercise, the Company will pay a cash
adjustment in
respect of the fraction in an amount equal to the fraction multiplied
by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name
of the Holder and
will not charge the Holder for any issue or transfer tax or other
incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any
manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares
of its Common
Stock or any other Common Stock Equivalent (which, for avoidance
of doubt, does
not include any shares of Common Stock issued by the Company pursuant
to this
Warrant), (ii) subdivides outstanding shares of Common Stock into
a larger
number of shares, (iii) combines outstanding shares of Common Stock
into a
smaller number of shares, or (iv) issues by reclassification of
shares of the
Common Stock any shares of capital stock of the Company, then the
Exercise Price
must be multiplied by a fraction of which the numerator is the
number of shares
of Common Stock (excluding treasury shares, if any) outstanding
before the event
and of which the denominator is the number of shares of Common
Stock outstanding
after the event, and the number of shares issuable upon exercise
of this Warrant
must be proportionately adjusted by this fraction. Any adjustment
made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination
of
stockholders entitled to receive the dividend or distribution and
is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii)
the Company
sells all or substantially all of its assets in one or a series
of related
transactions, (iii) any Person completes a tender offer or exchange
offer by
which holders of Common Stock are permitted to tender or exchange
their shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant
to which the
Common Stock is effectively converted into or exchanged for other
securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has
the right to
receive, for each Warrant Share that would have been issued upon
the exercise
absent the Fundamental Transaction, the same consideration as the
Company has
given its other holders of its Common Stock for the conversion
of their Common
Stock outstanding at the time of the Fundamental Transaction (the
“Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing
provisions with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor
or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly
adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock
outstanding at
any given time does not include shares of Common Stock owned or
held by or for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding
as of a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a
description of
the event that required the adjustment. If the Company proposes
any transaction
that affects the rights of the holders of its Common Stock, then
the Company
will notify the Holders of the proposal at least twenty days before
the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and
will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other
rights as a
shareholder of the Company before the Exercise Date. Upon the surrender
of this
Warrant and the payment of the aggregate Exercise Price, the Company
will issue
the Warrant Shares to the Holder as the record owner of the Warrant
Shares as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence
reasonably
satisfactory to it of the loss, theft, destruction or mutilation
of this Warrant
or any stock certificate relating to the Warrant Shares, and, in
case of loss,
theft or destruction, of indemnity or security reasonably satisfactory
to it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock
certificate
of like tenor and dated as of the cancellation, in lieu of the
Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday,
Sunday or a
legal holiday, then the thing may be done on the next succeeding
Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will
reserve from
its authorized and unissued Common Stock a sufficient number of
shares to
provide for the issuance of the Warrant Shares upon the exercise
of any purchase
rights under this Warrant. The Company further covenants that its
issuance of
this Warrant constitutes full authority to its officers who are
charged with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase
rights
under this Warrant. The Company will take all such reasonable action
as may be
necessary to assure that the Warrant Shares are issued as provided
without a
violation of any applicable law or regulation, or of any requirements
of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any
action avoid
or seek to avoid the observance or performance of any of the terms
of this
Warrant, but will at all times in good faith assist in carrying
out of all its
terms and take whatever actions is necessary or appropriate to
protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and
interpretation
of this Warrant must be determined in accordance with the provisions
of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed
by state and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right
hereunder on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given
or delivered
by either party to the other must be delivered in accordance with
the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit
of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both
the Company and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted
under
applicable law, but if any provision of this Warrant is prohibited
by or invalid
under applicable law, the provision is ineffective to the extent
of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference
only and are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant
(only if
exercised in full; if exercised in part, attach a copy of the
Warrant), and
tenders herewith payment of the exercise price in full, together
with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Beskivest Chart Ltd.
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 25th November, 2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Beskivest
Chart
Ltd.
Country
of incorporation or
residence:
Bahamas
Signature
of Authorized Signatory of Purchaser:
/s/ Brussels Management Ltd, represented by
/s/
X.
XxxXxxxxx
Name
of
Authorized Signatory: X. XxxXxxxxx for Brussels Management
Ltd.
Title
of
Authorized Signatory: Corporate
Director
Email
Address of Purchaser:
____________________________________________________
Address
for notice of Purchaser:
________________________________________________
Xxxxxxx'x
Xxx Xxxxxxxxx Xxxxxx
Xxxx
Xxx Xx. & Seaview Drive
P.O.
Box CB 10976
Nassau,
Bahamas
Address
for delivery of Securities for Purchaser (if not same as above):
Subscription
Amount: $ 100,000.00
Shares:
200,000 (in total we received 266,666 - special agreement)
Warrant
Shares: ________________________________
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 11/25/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable
have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal
opinion
of counsel to the transferor to such effect, the substance of which will
be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have
been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and
the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 200,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Beskivest
Chart Ltd.
(“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given
above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
200,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the
same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
12/16/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after
the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise
of this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d)
of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in
the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder
may
rely on the number of outstanding shares of Common Stock as reflected in
the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of
Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued,
fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount
is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by
the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its
Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to
this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into
a
smaller number of shares, or (iv) issues by reclassification of shares of
the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of
shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this
Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer
by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant to which
the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right
to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company
has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat
the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights
as a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will
issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant
or any stock certificate relating to the Warrant Shares, and, in case of
loss,
theft or destruction, of indemnity or security reasonably satisfactory to
it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or
stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve
from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of
the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action
avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder
on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and
binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or
invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 44,444
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Beskivest
Chart Ltd.
(“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
44,444
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 5/2/2005,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Hannah Hochwimmer
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM
IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 11/28/2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including
its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and
each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on
the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged,
the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as
these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants
under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed
and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time
entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at
any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares
and the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as
such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect
as such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to
this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available
funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to
each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of
the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to
each of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required
to be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued
and
are fully paid, non-assessable and free of preemptive and similar rights
to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational
or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted
or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and
to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of
the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium
and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the
Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and
clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale
of the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt
of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on
its
behalf has provided any of the Purchasers or their agents or counsel with
any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other
than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or
sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that
no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation
its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of
set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized
by all
necessary corporate or similar action on the part of the Purchaser. Each
of the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not
limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed
any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and
is able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published
in any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or
for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States,
other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf
or on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock
of the
Company, including, but not limited to, effecting any sale or short sale
of the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated
by it
are not part of a plan or scheme to evade the registration provisions of
the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through
the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have
not
conducted any Directed Selling Effort as that term is used and defined in
Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations
or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the
United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other
than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the
Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any
of the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder.
The
securities evidenced by this certificate cannot be transferred, offered,
or sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting
on its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any
Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company
to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with
any
obligations it may have under Regulation M with respect to the resale of
the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party
to xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any,
and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter
and
supersede all prior agreements and understandings, oral or written, with
respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective
on the
earliest of (a) the date of transmission, if the notice or communication
is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m.
(Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be
given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a
part of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must
be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and
federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents,
and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action
or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and
the
parties will attempt to agree upon a valid and enforceable provision that
is a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several
and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be
deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers
are in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser
to be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Hannah Hochwimmer
Country
of incorporation or residence: Germany
Signature
of Authorized Signatory of Purchaser:
/s/
Xxxxxx Hochwimmer
Name
of
Authorized Signatory: Georg Hochwimmer
Title
of
Authorized Signatory:___________________________________________
Email
Address of Purchaser: xxxxxxxxxx@xxxxxxxxxxxxxxx.xx
Address
for notice of Purchaser: Am Griesberg 19, X-00000,
Xxxxxxxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
______________________________________________________________
______________________________________________________________
Subscription
Amount: $13,500
Shares:
27,000
Warrant
Shares: 27,000
Date:
October 28th, 2005
[Purchasers’
signature pages continue]
15
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 11/28/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal opinion
of counsel to the transferor to such effect, the substance of which will be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 27,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Hannah
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
27,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
11/28/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 2,333
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Hannah
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 2,333
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 6,777
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Hannah
Hochwimmer (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 6,777
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 4/29/2005,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Xxxxx Xxxxxxxxx
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 1/23/2006,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Xxxxx Xxxxxxxxx
Country
of incorporation or residence: Switzerland
Signature
of Authorized Signatory of Purchaser:
/s/
Xxxxx Xxxxxxxxx
Name
of
Authorized Signatory: Xxxxx Xxxxxxxxx
Title
of
Authorized Signatory:___________________________________________
Email
Address of Purchaser: xxxxxxxxx@x-xxxxxx.xx
Address
for notice of Purchaser: Xxxxxxxxx 0, XX-0000, Xxxxxxxxxx,
Xxxxxxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
______________________________________________________________
______________________________________________________________
Subscription
Amount: $13,500
Shares:
27,000
Warrant
Shares: _____________________
Date:
January 14th, 2006
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 1/23/06,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable
have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal
opinion
of counsel to the transferor to such effect, the substance of which will
be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have
been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and
the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 27,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxx
Xxxxxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given
above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
27,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the
same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
1/23/2006, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after
the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise
of this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d)
of the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in
the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder
may
rely on the number of outstanding shares of Common Stock as reflected in
the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of
Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued,
fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount
is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by
the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its
Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to
this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into
a
smaller number of shares, or (iv) issues by reclassification of shares of
the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of
shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this
Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer
by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies
its
Common Stock or completes any compulsory share exchange pursuant to which
the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right
to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company
has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction
must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat
the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights
as a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will
issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant
or any stock certificate relating to the Warrant Shares, and, in case of
loss,
theft or destruction, of indemnity or security reasonably satisfactory to
it,
and upon surrender and cancellation of the Warrant or stock certificate,
if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or
stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve
from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of
the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action
avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder
on the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and
binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or
invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions
of this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 9,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxx
Xxxxxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 9,000
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Xxxxx Xxxxxx
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of Dec. 19, 2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Xxxxx Xxxxxx
Country
of incorporation or
residence:
Signature
of Authorized Signatory of Purchaser:
/s/ Xxxxx Xxxxxx
Name
of
Authorized
Signatory:
Title
of
Authorized
Signatory:
Email
Address of Purchaser: ______Xxxxxxx@xxxxxxx.xxx
Address
for notice of Purchaser: 20th floor, 000 Xxxxxxx Xx., Xxxxxxxxx, X.X. X0X
0X0
Address
for delivery of Securities for Purchaser (if not same as above):
_______________________________________________________________________
_______________________________________________________________________
Subscription
Amount: $25,000.00
Shares:
50,000
Warrant
Shares: ________________________________
Date:
Dec. 19, 2005
[Purchasers’
signature pages continue]
Please
Register the Shares to:
Xxxxxxx
Securities Inc.
IRF
Xxxxx Xxxxxx
#0000-000
Xxxxxxx Xxxxxx
Xxxxxxxxx,
XX X0X 0X0
Please
Deliver the Shares to:
Xxxxxxx
Securites Inc.
#0000-000
Xxxxxxx Xxxxxx
Xxxxxxxxx,
XX X0X 0X0
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 12/19/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal opinion
of counsel to the transferor to such effect, the substance of which will be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 50,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value
received, Xxxxx Xxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
50,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
12/20/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 11,111
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxx Xxxxxx
(“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
11,111
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 5/2/2005,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Xxxxxxx Xxxxxx
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 11/14/2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Xxxxxxx Xxxxxx
Country
of incorporation or residence: Germany
Signature
of Authorized Signatory of Purchaser:
/s/ X.
Xxxxxx
Name
of
Authorized Signatory: Xx. Xxxxxxx Xxxxxx
Title
of
Authorized Signatory:___________________________________________
Email
Address of Purchaser: xxxxxx@xxxxxxxxxxxx.xx
Address
for notice of Purchaser: xxxxxxxxxxx. 00, 00000 Xxxxxxxx,
Xxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
______________________________________________________________
______________________________________________________________
Subscription
Amount: $25,000
Shares:
50,000
Warrant
Shares: _____________________
Date:
November 14th, 2005
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 11/14/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal opinion
of counsel to the transferor to such effect, the substance of which will be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 50,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xx. Xxxxxxx
Xxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
50,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
11/14/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 8,333
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxxxx
Xxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 8,333
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
XXXXX-XXXX XXXXXXX
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of November 18th, 2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: XXXXX-XXXX XXXXXXX
Country
of incorporation or residence: Germany
Signature
of Authorized Signatory of Purchaser:
/s/
Xxxxx-Xxxx Xxxxxxx
Name
of
Authorized Signatory: Xxxxx-Xxxx Xxxxxxx
Title
of
Authorized Signatory:
Email
Address of Purchaser: xxxxx@xxxxxxx.xxx
Address
for notice of Purchaser: Xxxxxxxxxxxxx 0, 00000 Xxxxxx,
Xxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
______________________________________________________________
______________________________________________________________
Subscription
Amount: $175.000
Shares:
350.000
Warrant
Shares: 350.000
Date:
November 18th, 2005
[Purchasers’
signature pages continue]
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 11/18/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal opinion
of counsel to the transferor to such effect, the substance of which will be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 350,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxx-Xxxx
Xxxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
350,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
11/17/2005, among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 11,167
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxx-Xxxx
Xxxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to 11,167
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
Xxxxxx X. Xxxxxx
THE
SECURITIES SOLD HEREUNDER HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, PURSUANT TO
REGULATION S THEREUNDER. THE SECURITIES SOLD HEREUNDER CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement
(this
“Agreement”)
is
dated as of 10/12/2005,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser”
and
collectively the “Purchasers”);
and
Whereas,
subject
to the terms and conditions set forth in this Agreement and pursuant to Section
4(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company
in
the aggregate, up to $7,500,000 of shares of Common Stock and Warrants on the
Closing Date.
In
consideration
of the
mutual covenants contained in this Agreement, and for other good and valuable
consideration the receipt and adequacy of which are hereby acknowledged, the
Company and each Purchaser agrees as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions
For
all purposes of this Agreement:
“Affiliate”
means
any Person that, directly or indirectly through one or more intermediaries,
controls or is controlled by or is under common control with a Person as these
terms are used in and construed under Rule 144, and any investment fund or
managed account that is managed on a discretionary basis by the same investment
manager as a Purchaser.
“Closing”
means
the closing of the purchase and sale of the Common Stock and the Warrants under
Section 2.1.
“Closing
Date”
means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties.
“Commission”
means
the Securities and Exchange Commission.
“Common
Stock”
means
the common shares of the Company with a par value of $0.001 per share, and
any
securities into which the common shares might be reclassified.
1
“Common
Stock Equivalents”
means
any securities of the Company or the Subsidiaries that would at any time entitle
the holder to acquire Common Stock, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock.
“Effective
Date”
means
the date that the Registration Statement is first declared effective by the
Commission.
“Liens”
means
a
lien, charge, security interest, encumbrance, and right of first refusal,
preemptive right or other restriction.
“Material
Adverse Effect”
is
defined in Section 3.1(b).
“Per
Share Purchase Price”
equals
$0.75,
subject
to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur
after
the date of this Agreement.
“Person”
means
an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Proceeding”
means an
action, claim, suit, investigation or proceeding (including, without limitation,
an investigation or partial proceeding, such as a deposition), whether commenced
or threatened.
“Registration
Rights Agreement”
means
the Registration Rights Agreement, dated as of the date of this Agreement,
among
the Company and each Purchaser, in the form of the attached Exhibit
A.
“Registration
Statement”
means
a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Purchasers of the Shares and
the
Warrant Shares.
“Required
Approvals”
is
defined in Section 3.1(e).
“Rule
144”
means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as
such
Rule.
“Securities”
means
the Shares, the Warrants and the Warrant Shares.
“Securities
Act”
means
the Securities Act of 1933.
“Shares”
means
the shares of Common Stock issued or issuable to each Purchaser under to this
Agreement.
2
“Subscription
Amount”
means,
as to each Purchaser, the amount set below each Purchaser’s signature block on
the signature page, in United States dollars and in immediately available funds.
“Subsidiary”
means
any subsidiary of the Company and any future direct or indirect subsidiary
of
the Company.
“Trading
Day”
means
a
day on which the Common Stock is quoted or traded on a Trading
Market.
“Trading
Market”
means
the American Stock Exchange, the New York Stock Exchange, the Nasdaq National
Market, the Nasdaq SmallCap Market or the OTC Bulletin Board.
“Transaction
Documents”
means
this Agreement, the Warrants and the Registration Rights Agreement and any
other
documents or agreements executed in connection with the transactions
contemplated hereunder.
“Warrants”
means
the Common Stock Purchase Warrants in the form of the attached Exhibit
B.
“Warrant
Shares”
means
the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
On the
Closing Date, each Purchaser will purchase from the Company, severally and
not
jointly with the other Purchasers, and the Company will issue and sell to each
Purchaser, (a) a number of Shares equal to such Purchaser’s Subscription Amount
divided by the Per Share Purchase Price and (b) the Warrants as determined
pursuant to Section 2.2(a)(iii).
The
aggregate Subscription Amounts for the Shares sold hereunder will be a maximum
of $5,000,000. Upon satisfaction of the conditions set forth in Section
2.3,
the
Closing will occur at the offices of the Company or such other location as
the
parties will mutually agree.
2.2 Deliveries.
(a) On
the
Closing Date, the Company will deliver or cause to be delivered to each
Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) a
certificate evidencing a number of Shares equal to the Purchaser’s Subscription
Amount divided by the Per Share Purchase Price, registered in the name of the
Purchaser;
3
(iii) a
Warrant, registered in the name of the Purchaser, pursuant to which the
Purchaser has the right to acquire up to the number of shares of Common Stock
equal to 100% of the Shares to be issued to the Purchaser; and
(iv) the
Registration Rights Agreement duly executed by the Company.
(b) On
the
Closing Date, each Purchaser will deliver or cause to be delivered to the
Company the following:
(i) this
Agreement duly executed by the Purchaser;
(ii) the
Purchaser’s Subscription Amount by wire transfer as per the wire instructions
provided by the Company; and
(iii) the
Registration Rights Agreement duly executed by the Purchaser.
2.3 Closing
Conditions.
(a) The
obligations of the Company in connection with the Closing are subject to each
of
the following conditions being met:
(i) The
representations and warranties of the Purchasers are accurate in all material
respects when they were made and on the Closing date
(ii) The
Purchasers have performed all obligations, covenants and agreements required
to
be performed by the Closing Date.
(iii) The
Purchasers have delivered the items set forth in Section 2.2(b)
of this
Agreement.
(b) The
respective obligations of the Purchasers in connection with the Closing are
subject to each of the following conditions being met:
(i) The
representations and warranties of the Company are accurate in all material
respects on the Closing Date
(ii) The
Company has performed all obligations, covenants and agreements required to
be
performed by the Closing Date.
(iii) The
Company has delivered the items set forth in Section 2.2(a)
of this
Agreement.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations
and Warranties of the Company.
The
Company represents and warrants to each Purchaser:
4
(a) Subsidiaries.
The
Company owns, directly or indirectly, all of the capital stock or other equity
interests of each Subsidiary free and clear of any Liens, and all the issued
and
outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities.
(b) Organization
and Qualification.
Each of
the Company and the Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization (as applicable), with the
requisite power and authority to own and use its properties and assets and
to
carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or
charter documents. Each of the Company and the Subsidiaries is duly qualified
to
conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing could not reasonably be expected
to have (i) a material adverse effect on the legality, validity or
enforceability of any Transaction Documents, (ii) a material adverse effect
on
the results of operations, assets, business, prospects or financial condition
of
the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse
effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under any Transaction Documents (any of (i), (ii) or
(iii), a “Material
Adverse Effect”)
and no
Proceeding has been instituted in any such jurisdiction revoking, limiting
or
curtailing or seeking to revoke, limit or curtail such power and authority
or
qualification.
(c) Authorization;
Enforcement.
The
Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents
and otherwise to carry out its obligations under them. The Company’s execution
and delivery of each of the Transaction Documents and its consummation of the
transactions contemplated by them have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in their connection other than in connection with the Required
Approvals. Each Transaction Documents has been (or upon delivery will have
been)
duly executed by the Company and, when delivered in accordance with the terms
hereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights
generally and (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies.
(d) No
Conflicts.
The
Company’s execution, delivery and performance of the Transaction Documents, its
issuance and sale of the Shares and its consummation of the other transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s or any Subsidiary’s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii)
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal
and
state securities laws and regulations).
5
(e) Filings,
Consents and Approvals.
The
Company is not required to obtain any consent, waiver, authorization or order
of, give any notice to, or make any filing or registration with, any court
or
other federal, state, local or other governmental authority or other Person
in
connection with its execution, delivery and performance of the Transaction
Documents, other than (i) the filing with the Commission of the Registration
Statement, and (ii) any filings that are required by applicable federal and
state securities laws (collectively, the “Required
Approvals”).
(f) Issuance
of the Securities.
The
Shares and Warrants are duly authorized and, when issued and paid for in
accordance with the Transaction Documents, will be duly and validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents.
The Warrant Shares, when issued in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly
authorized capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants.
(g) Private
Placement.
Assuming the accuracy of the Purchasers representations and warranties set
forth
in Section 3.2,
no
registration under the Securities Act is required for the offer and sale of
the
Securities by the Company to the Purchasers. The issuance and sale of the
Securities does not contravene the rules and regulations of the Trading
Market.
(h) Investment
Company.
The
Company is not, and is not an Affiliate of, and immediately after receipt of
payment for the Shares, will neither be nor be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as amended.
The Company will conduct its business in such a manner that it will not become
subject to the Investment Company Act.
(i) Disclosure.
The
Company confirms that neither the Company nor any other Person acting on its
behalf has provided any of the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public
information. All disclosure provided to the Purchasers regarding the Company,
its business and the transactions contemplated by it furnished by or on behalf
of the Company with respect to the representations and warranties are true
and
correct and do not contain any untrue statement of a material fact or omit
to
state any material fact necessary in order to make the statements, in light
of
the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2.
6
(j) General
Solicitation.
Neither
the Company nor any person acting on behalf of the Company has offered or sold
any of the Shares by any form of general solicitation or general advertising.
The Company has offered the Shares for sale only to the Purchasers and certain
other “accredited investors” within the meaning of Rule 501 under the Securities
Act.
(k) Acknowledgment
Regarding Purchasers’ Purchase of Shares.
The
Company acknowledges that each of the Purchasers is acting solely in the
capacity of an arm’s length purchaser with respect to the Transaction Documents
and the transactions contemplated. The Company further acknowledges that no
Purchaser is acting as a financial advisor or fiduciary of the Company (or
in
any similar capacity) with respect to this Agreement and the transactions
contemplated and any advice given by any Purchaser or any of their respective
representatives or agents in connection with this Agreement and the transactions
contemplated is merely incidental to the Purchasers’ purchase of the Shares. The
Company further represents to each Purchaser that the Company’s decision to
enter into this Agreement has been based solely on the independent evaluation
of
the transactions contemplated by the Company and its representatives.
(l) Acknowledgment
of Dilution.
The
Company acknowledges that the issuance of the Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial
under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including without limitation its
obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such
dilution or any claim the Company may have against any Purchaser and regardless
of the dilutive effect that such issuance may have on the ownership of the
other
stockholders of the Company.
Purchaser
acknowledges that the Company does not make or has not made any representations
or warranties with respect to the transactions contemplated other than those
specifically set forth in this Section 3.1.
3.2 Representations
and Warranties of the Purchasers.
Each
Purchaser hereby, for itself and for no other Purchaser, represents and warrants
as of the date hereof and as of the Closing Date to the Company as
follows:
(a) Organization
Authority.
The
Purchaser is an entity duly organized, validly existing and in good standing
under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate
the
transactions contemplated by the Transaction Documents and otherwise to carry
out its obligations. The execution, delivery and performance by the Purchaser
of
the transactions contemplated by this Agreement have been duly authorized by
all
necessary corporate or similar action on the part of the Purchaser. Each of
the
Transaction Documents to which it is a party has been duly executed by the
Purchaser, and when delivered by the Purchaser in accordance with these terms,
constitutes the valid and legally binding obligation of the Purchaser,
enforceable against it in accordance with its terms, except as limited by
applicable law.
7
(b) Investment
Intent.
The
Purchaser understands that the Securities are “restricted securities” and have
not been registered under the Securities Act or any applicable state securities
law and that Purchaser is acquiring the Securities as principal for its own
account and not with a view to or for distributing or reselling any of the
Securities, has no present intention of distributing any of such Securities,
and
has no arrangement or understanding with any other persons regarding the
distribution of the Securities (this representation and warranty does not limit
the Purchaser’s right to sell the Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state
securities laws). Purchaser is acquiring the Securities in the ordinary course
of its business. Purchaser does not have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the
Securities.
(c) Disclosure
of Information.
Purchaser carefully reviewed all filings made by the Company with the Commission
as of the date of this Agreement and has received and carefully reviewed any
information Purchaser has requested from the Company that Purchaser considers
necessary or appropriate for deciding whether to acquire the Securities,
including, without limitation, all material risk factors relating to the
Company. Purchaser further represents that Purchaser has had ample opportunity
to ask questions and receive answers from the Company concerning the information
and the terms and conditions of the offering of the Securities and to obtain
any
additional information necessary to verify the accuracy of the information
given
to Purchaser. Purchaser is making its investment in the Company after having
reviewed, analyzed, sought professional advice regarding, and fully
understanding the risk, uncertainties, and liabilities associated with the
Company.
(d) Experience
of Such Purchaser.
Purchaser, either alone or together with its representatives, is knowledgeable,
sophisticated, and experienced in business and financial matters and is capable
of evaluating the merits and risks of the prospective investment in the
Securities, and has evaluated the merits and risks of the investment. Purchaser
is able to bear the economic risk of an investment in the Securities and is
able
to afford a complete loss of the investment.
(e) General
Solicitation.
Purchaser is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar or any other general solicitation or general
advertisement.
(f) Regulation
S.
(i) Purchaser
either has been duly formed and is validly existing as a corporation or other
legal entity in good standing under the laws of its jurisdiction of
incorporation set forth on the signature page to this Agreement or is an
individual who is not a citizen or resident of the United States. Purchaser
is
not organized under the laws of the United States and is not a “U.S. Person” as
that term is defined in Rule 902(o) of Regulation S.
8
(ii) Purchaser
was not formed for the purpose of investing in Regulation S securities or for
the purpose of investing in the Securities sold under this Agreement. Purchaser
is not registered as an issuer under the Securities Act and is not required
to
be registered with the SEC under the Investment Company Act of 1940, as amended.
Purchaser is entering into this Agreement and is participating in the offering
of the Shares for its own account, and not on behalf of any U.S. Person as
defined in Rule 902(o) of Regulation S.
(iii) The
Company has not made an offer to enter into this Agreement to Purchaser in
the
United States other than as permitted in the case of an account managed by
a
professional fiduciary resident in the United States within the meaning of
Section 902(o)(2) of Regulation S. At the times of the offer and execution
of
this Agreement and, to the best knowledge of Purchaser, at the time the offering
originated, Purchaser was located and resident outside the United States, other
than as permitted in the case of an account managed by a professional fiduciary
resident in the United States within the meaning of Section 902(o)(2) of
Regulation S.
(iv) Neither
Purchaser, nor any of its Affiliates, nor any person acting on its behalf or
on
behalf of any Affiliate has engaged or will engage in any activity undertaken
for the purpose of, or that reasonably could be expected to have the effect
of,
conditioning the markets in the United States for the Shares or for any
securities that are convertible into or exercisable for the common stock of
the
Company, including, but not limited to, effecting any sale or short sale of
the
Company’s securities through Purchaser or any of its Affiliates before the
expiration of any restricted period contained in Regulation S. To the best
knowledge of Purchaser, this Agreement and the transactions contemplated by
it
are not part of a plan or scheme to evade the registration provisions of the
Securities Act, and Purchaser is purchasing the Shares for investment purposes.
Purchaser and, to the best knowledge of Purchaser, each distributor, if any,
participating in this offering of the Securities have agreed that they will
neither offer nor sell any Securities before the date hereof and through the
expiration of the any restricted period set forth in Rule 903 of Regulation
S
(as amended from time to time) to U.S. Persons or for the account or benefit
of
U.S. Persons, and they will offer or sell any of the Securities only in
compliance with the provisions of Regulation S and any other applicable
provisions of the Securities Act. Purchaser and its representatives have not
conducted any Directed Selling Effort as that term is used and defined in Rule
902 of Regulation S and will not engage in any Directed Selling Effort within
the United States through the expiration of any restricted period set forth
in
Rule 903 of Regulation S.
(v) Purchaser
acknowledges that following the expiration of any restricted period provided
by
Rule 903 of Regulation S, any interest in this Agreement or in the Securities
sold may be resold within the jurisdiction of the United States or to U.S.
Persons as defined in Rule 902(o) of Regulation S by or for the account of
the
parties only (i) pursuant to a registration statement under the Securities
Act,
or (ii) if applicable, pursuant to an exemption from registration for sales
by a
person other than an issuer, underwriter, or dealer as those terms are used
in
Section 4(1) and related provisions of the Securities Act and regulations or
pursuant to another exemption from registration, only following the expiration
of any restricted period (if applicable) required by Regulation S. Purchaser
acknowledges that this Agreement and the Securities have not been registered
under the Securities Act or qualified under state securities laws of the United
States and that their transferability within the jurisdiction of the United
States is restricted by the Securities Act as well as state laws. Purchaser
acknowledges it has received a copy of Regulation S, is familiar with and
understands its terms, and has had the opportunity to consult with its legal
counsel concerning this Agreement and Regulation S.
9
The
Company acknowledges that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated
other than those specifically set forth in this Section 3.2.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The
Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of the Securities other than
pursuant to an effective registration statement or in compliance with Regulation
S and Rule 144, the Company may require the transferor to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable
to
the Company, the form and substance of which opinion must be reasonably
satisfactory to the Company, to the effect that the transfer does not require
registration of the transferred Securities under the Securities Act. As a
condition of transfer, any transferee must agree in writing to be bound by
the
terms of this Agreement and will have the rights of a Purchaser under this
Agreement and the Registration Rights Agreement.
(b) The
Purchaser agrees to the imprinting, so long as it is required under the
Securities Act and the rules and regulations promulgated under it, on any of
the
Securities any of the following legends or substantially similar
legends:
THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO
SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE
COMPANY.
10
These
securities have been issued pursuant to an exemption from registration under
the
Securities Act of 1933, as amended, pursuant to Regulation S thereunder. The
securities evidenced by this certificate cannot be transferred, offered, or
sold
in the United States or to U.S. Persons (as that term is defined in Regulation
S) except pursuant to registration under the Securities Act of 1933, or pursuant
to an available exemption from registration.
4.2 Non-Public
Information.
The
Company covenants and agrees that neither it nor any other Person acting on
its
behalf will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless
Purchaser has first executed a written agreement regarding the confidentiality
and use of the information.
4.3 Use
of Proceeds.
The
Company will use the net proceeds from the sale of the Securities for working
capital purposes, current debt and trade payables, and not to redeem any Common
Stock or Common Stock Equivalents or to settle any outstanding
litigation.
4.4 Reservation
of Common Stock.
As of
the date hereof, the Company has reserved and the Company will continue to
reserve and keep available at all times, free of preemptive rights, a sufficient
number of shares of Common Stock for the purpose of enabling the Company to
issue the Shares and Warrant Shares on any exercise of the Warrants.
4.5 Delivery
of Securities after Closing.
The
Company will deliver, or cause to be delivered, the respective Shares and
Warrants purchased by each Purchaser to the Purchaser within 3 Trading Days
of
the Closing Date.
4.6 Resale
by Purchaser.
Each
Purchaser understands and acknowledges, severally and not jointly with any
other
Purchaser, that the SEC takes the position that the coverage of short sales
of
shares of the Common Stock “against the box” before the Effective Date of the
Registration Statement with the Shares is a violation of Section 5 of the
Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.
Accordingly, no Purchaser will use any of the Shares to cover any short sales
made before the Effective Date. Further, each Purchaser will comply with any
obligations it may have under Regulation M with respect to the resale of the
Securities.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This
Agreement may be terminated by any party, by written notice to the other
parties, if the Closing has not taken place by the end of thirty days from
the
date of this Agreement; but no termination affects the right of any party to
xxx
for any breach by the other party (or parties).
5.2 Fees
and Expenses.
Except
as otherwise set forth in this Agreement, each party will pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by the party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company
will pay all stamp and other taxes and duties levied in connection with the
delivery of the Securities.
11
5.3 Entire
Agreement.
The
Transaction Documents, together with their exhibits and schedules, contain
the
entire understanding of the parties with respect to their subject matter and
supersede all prior agreements and understandings, oral or written, with respect
to these matters, which the parties acknowledge have been merged into the
Transaction Documents and their exhibits and schedules.
5.4 Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be in writing and are deemed given and effective on
the
earliest of (a) the date of transmission, if the notice or communication is
delivered via facsimile at the facsimile number set forth on the signature
attached pages before 6:30 p.m. (Reno, Nevada, time) on a Trading Day, (b)
the
next Trading Day after the date of transmission, if the notice or communication
is delivered via facsimile at the facsimile number set forth on the signature
attached pages on a day that is not a Trading Day or later than 6:30 p.m. (Reno,
Nevada, time) on any Trading Day, (c) the second Trading Day following the
date
of mailing, if sent by U.S. nationally recognized overnight courier service,
or
(d) upon actual receipt by the party to whom the notice is required to be given.
The address for notices and communications are as set forth on the attached
signature pages.
5.5 Amendments
Waivers.
No
provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and each
Purchaser or, in the case of a waiver, by the party against whom enforcement
of
any waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement is deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement, nor does any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of
the
right.
5.6 Construction.
The
headings in this Agreement are for convenience only, do not constitute a part
of
this Agreement, and cannot be deemed to limit or affect any of the provisions.
The language used in this Agreement is deemed to be the language chosen by
the
parties to express their mutual intent, and no rules of strict construction
can
be applied against any party.
5.7 Successors
and Assigns.
This
Agreement binds and inures to the benefit of the parties and their successors
and permitted assigns and is not assignable.
5.8 No
Third-Party Beneficiaries.
This
Agreement is intended for the benefit of the parties and their respective
successors and permitted assigns and is not for the benefit of, nor may any
provision be enforced by, any other Person.
12
5.9 Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents must be governed by and construed and enforced
in
accordance with the internal laws of the State of Nevada,
without
regard to the principles of conflicts of law. All legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated
by
the Transaction Documents (whether brought against a party or its respective
affiliates, directors, officers, shareholders, employees or agents) must be
commenced exclusively in the state and federal courts sitting in Reno.
Each
party irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in Reno
for the
adjudication of any dispute in connection with the Transaction Documents, and
irrevocably waives, and will not assert in any suit, action or proceeding,
any
claim that it is not personally subject to the jurisdiction of any such court,
that it is an improper or inconvenient venue for the proceeding. The parties
waive all rights to a trial by jury. If either party commences an action or
proceeding to enforce any provisions of the Transaction Documents, then the
non-prevailing party in the action or proceeding will reimburse the prevailing
party for its attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of the action or
proceeding.
5.10 Execution.
This
Agreement may be executed in two or more counterparts and delivered to the
other
parties by any means; and the counterparts, taken together, are considered
one
and the same agreement, and any electronically delivered signature page is
deemed to be an originally signed document.
5.11 Severability.
If any
provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement are not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is
a
reasonable substitute, and upon so agreeing, will incorporate the substitute
provision in this Agreement.
5.12 Replacement
of Securities.
If any
certificate or instrument evidencing any Securities is mutilated, lost, stolen
or destroyed, the Company will issue or cause to be issued in exchange and
substitution for and upon its cancellation, or in lieu of and substitution,
a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft or destruction and customary
and
reasonable indemnity, if requested. An applicant for a new certificate or
instrument under such circumstances will pay any reasonable third-party costs
associated with the issuance of the replacement Securities.
5.13 Remedies.
In
addition to being entitled to exercise all rights provided herein or granted
by
law, including recovery of damages, each of the Purchasers and the Company
is
entitled to specific performance under the Transaction Documents.
5.14 Independent
Nature of Purchasers’ Obligations and Rights.
The
obligations of each Purchaser under the Transaction Documents are several and
not joint with the obligations of any other Purchaser, and no Purchaser is
responsible in any way for the performance of the obligations of any other
Purchaser under the Transaction Documents. Nothing contained in any Transaction
Documents, and no action taken by any Purchaser pursuant to them, can be deemed
to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are
in
any way acting in concert or as a group with respect to the obligations or
the
transactions contemplated by the Transaction Documents. Each Purchaser is
entitled to independently protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement or out of the other
Transaction Documents, and it is not be necessary for any other Purchaser to
be
joined as an additional party in any proceeding for this purpose. Each Purchaser
has been represented by its own separate legal counsel in their review and
negotiation of the Transaction Documents. The Company has elected to provide
all
Purchasers with the same terms and Transaction Documents for the convenience
of
the Company and not because it was required or requested to do so by the
Purchasers.
13
(Signature
pages follow.)
In
witness whereof,
the
parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.
BULLION
RIVER GOLD CORP.
|
Address
for Notice:
|
By:/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
0000
Xxxxxxxx Xxxxx, Xxxxx 000
Xxxx,
XX 00000
Fax:
000-000-0000
|
With
a copy to (which cannot constitute notice):
|
[Remainder
of page intentionally left blank.
Signature
pages for purchasers follow.]
14
[Purchasers’
signature pages to BLRV Securities Purchase Agreement]
In
witness whereof,
the
undersigned have caused this Securities Purchase Agreement to be duly executed
by their respective authorized signatories as of the date first indicated
above.
Name
of
Purchaser: Xxxxxx X.
Xxxxxx
Country
of incorporation or
residence: Switzerland
Signature
of Authorized Signatory of Purchaser:
/s/ Xxxxxx X. Xxxxxx
Name
of
Authorized
Signatory:
Title
of
Authorized
Signatory:
Email
Address of Purchaser: xxxxxx.xxxxxx@xxxxxx.xx
Address
for notice of Purchaser: Xxxxxxxxxxx 00, Xxxx Xxxxx /
Xxxxxxxxxxx
Address
for delivery of Securities for Purchaser (if not same as above):
to
Xxxxxxx & Xxxxxx LLC
00
Xxxxxxxx, Xxx Xxxx, XX 00000-0000
XXX
Subscription
Amount: for total US$25,000
Shares:
50,000 +
Warrant
Shares: 50,000+
@
50¢ p.
unit
Date:
Dec. 19, 2005
[Purchasers’
signature pages continue]
Please
Register the Shares to:
Xxxxxxx
Securities Inc.
IRF
Xxxxx Xxxxxx
#0000-000
Xxxxxxx Xxxxxx
Xxxxxxxxx,
XX X0X 0X0
Please
Deliver the Shares to:
Xxxxxxx
Securites Inc.
#0000-000
Xxxxxxx Xxxxxx
Xxxxxxxxx,
XX X0X 0X0
15
EXHIBIT
A
REGISTRATION
RIGHTS AGREEMENT
This
registration rights agreement (this “Agreement”)
is
made as of 10/12/05,
among
Bullion River Gold Corp., a Nevada corporation (the “Company”),
and
the purchasers (each a “Purchaser”
and
collectively, the “Purchasers”).
This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of
the
date of this Agreement among the Company and the Purchasers (the “Purchase
Agreement”).
The
Company and the Purchasers agree that:
1. Definitions.
Capitalized terms used and not otherwise defined in this Agreement have the
same
meanings as they have in the Purchase Agreement. As used in this
Agreement:
“Effectiveness
Period”
is
defined in Section 2.
“Filing
Date”
means
the 90th
calendar
day following the date of the Purchase Agreement.
“Holder”
or
“Holders”
means
the holder or holders from time to time of Registrable Securities.
“Indemnified
Party”
is
defined in Section 5(b).
“Indemnifying
Party”
is
defined in Section 5(b).
“Losses”
includes all losses, claims, damages, liabilities, costs, attorneys’ fees and
expenses.
“Proceeding”
means
an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.
“Prospectus”
means
the prospectus included in the Registration Statement, as amended or
supplemented by any prospectus supplement, whether pre- or post-effective and
all material incorporated by reference or deemed to be incorporated by reference
in the prospectus.
“Registrable
Securities”
means
all of the Shares and the Warrant Shares, together with any shares of Common
Stock issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event that affects the Shares or the Warrant
Shares.
“Registration
Statement”
means
the registration statements required to be filed hereunder, including the
Prospectus, amendments and supplements to the registration statement or
Prospectus, whether pre- and post-effective amendments, all exhibits to them,
and all material incorporated by reference or deemed to be incorporated by
reference in the registration statement.
1
“Rule
415”
means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
“Rule
424”
means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as
amended from time to time, or any similar rule or regulation hereafter adopted
by the Commission having substantially the same purpose and effect as this
Rule.
2. Registration.
By the
Filing Date, the Company will prepare and file with the Commission the
Registration Statement covering the resale of all of the Registrable Securities
for an offering to be made on a continuous basis pursuant to Rule 415. Subject
to the terms of this Agreement, the Company will use its best efforts to cause
the Registration Statement to be declared effective under the Securities Act
as
promptly as possible after its filing, but in any event not later than the
earlier of (a) the 180th
calendar
day following the date of the Purchase Agreement and (b) the fifth Trading
Day
following the date on which the Commission notifies the Company that it will
not
review the Registration Statement or that the Registration Statement is no
longer subject to review and comments; and will use its best efforts to keep
the
Registration Statement continuously effective under the Securities Act until
all
Registrable Securities covered by the Registration Statement have been sold
or
may be sold without volume restrictions pursuant to Rule 144(k) (the
“Effectiveness
Period”).
3. Registration
Procedures.
(a) Each
Holder will furnish to the Company a completed Questionnaire in the form
attached to this Agreement as Annex A at least five Trading Days before the
Filing Date or earlier at the Company’s request;
and
will furnish, at the Company’s request, a statement certifying the number of
shares of Common Stock beneficially owned by the Holder and, if required by
the
Commission, the name of the Person who has voting and dispositive control over
the Shares.
(b) The
Company will (i) prepare and file with the Commission the amendments to the
Registration Statement as may be necessary to keep the Registration Statement
continuously effective for the Registrable Securities for the Effectiveness
Period; (ii) respond as promptly as reasonably possible to any comments received
from the Commission with respect to the Registration Statement or any amendment;
and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of Registrable
Securities covered by the Registration Statement during the applicable
period.
(c) The
Company will use commercially reasonable efforts to avoid the issuance of,
or,
if issued, obtain the withdrawal of, (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification
(or
exemption from qualification) of any of the Registrable Securities for sale
in
any jurisdiction.
2
(d) The
Company will use its commercially reasonable efforts to register or qualify
or
cooperate with the selling Holders in connection with the registration or
qualification (or exemption from the Registration or qualification) of
Registrable Securities for the resale by the Holder under the securities or
Blue
Sky laws of the jurisdictions within the United States as any Holder reasonably
requests in writing, to keep the Registration or qualification (or exemption)
effective during the Effectiveness Period and to do any other acts or things
reasonably necessary to enable the disposition in those jurisdictions of the
Registrable Securities covered by the Registration Statement; provided, that
the
Company is not required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any material tax
in
any jurisdiction where it is not then so subject, or file a general consent
to
service of process in any such jurisdiction.
(e) The
Company will comply with all applicable rules and regulations of the
Commission.
(f) The
Company will notify the Holders immediately, with confirmation in writing,
if it
receives during the Effectiveness Period a notice from any federal or state
regulatory authority of any action that could affect the Holders’ ability to
sell the Registrable Securities.
4. Registration
Expenses.
The
Company will bear all fees and expenses that it incurs in performing or
complying with this Agreement whether or not any Registrable Securities are
sold
pursuant to the Registration Statement.
5. Indemnification
(a) Indemnification
by Holders.
Each
Holder will, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents and employees, each Person who controls the
Company (within the meaning of Section 15 of the Securities Act and Section
20
of the Exchange Act), and the directors, officers, agents or employees of the
controlling Persons, to the fullest extent permitted by applicable law, from
and
against all Losses arising out of or based solely upon (i) the Holder’s failure
to comply with the prospectus delivery requirements of the Securities Act or
(ii) any untrue or alleged untrue statement of a material fact contained in
any
Registration Statement, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated or necessary to make the
statements not misleading but only if the untrue statement or omission is
contained in written information furnished by the Holder to the Company
specifically for inclusion in the Registration Statement.
3
(b) Conduct
of Indemnification Proceedings.
If any
Proceeding is brought or asserted against any Person entitled to indemnity
under
this Agreement (an “Indemnified
Party”),
the
Indemnified Party will promptly notify the Person from whom indemnity is sought
(the “Indemnifying
Party”)
in
writing, and the Indemnifying Party may assume the defense, including the
employment of counsel reasonably satisfactory to the Indemnified Party, and
will
pay all fees and expenses incurred in connection with defense; but an
Indemnified Party’s failure to give the notice does not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, unless
a
court of competent jurisdiction (whose decision is not subject to appeal or
further review) decides that the failure has prejudiced the Indemnifying
Party.
Notwithstanding the foregoing, an Indemnified Party may employ separate counsel
in any Proceeding and participate in the defense, and will bear the expense
of
the counsel unless (i) the Indemnifying Party has agreed in writing to pay
the
fees and expenses, (ii) the Indemnifying Party has failed promptly to assume
the
defense of the Proceeding and to employ counsel reasonably satisfactory to
the
Indemnified Party, or (iii) the named parties to the Proceeding (including
any
impleaded parties) include both the Indemnified Party and the Indemnifying
Party, and the Indemnified Party reasonably believes that a material conflict
of
interest is likely to exist if the same counsel were to represent the
Indemnified Party and the Indemnifying Party (in which case, if the Indemnified
Party notifies the Indemnifying Party in writing that it elects to employ
separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party may not assume the defense and must bear the reasonable fees and expenses
of the separate counsel). The Indemnifying Party is not liable for any
settlement of any Proceeding without its written consent, which consent cannot
be unreasonably withheld. No Indemnifying Party will, without the prior written
consent of the Indemnified Party, settle any Proceeding that includes an
Indemnified Party unless the settlement includes an unconditional release of
the
Indemnified Party from all liability on the claims that are the subject matter
of the Proceeding. The Indemnifying Party will pay all reasonable fees and
expenses of the Indemnified Party (including reasonable fees and expenses
incurred in connection with investigating or preparing to defend a Proceeding
in
a manner consistent with this Section) to the Indemnified Party within ten
Trading Days of written notice to the Indemnifying Party.
(c) Contribution.
If a
claim for indemnification under Section 5(a)
is
unavailable to an Indemnified Party (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying the Indemnified Party,
will contribute to the amount paid or payable by the Indemnified Party as a
result of the Losses, in the proportion that is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in the Losses and any
other relevant equitable considerations. The relative fault of the Indemnifying
Party and Indemnified Party must be determined by referring to, among other
things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material
fact,
has been taken or made by, or relates to information supplied by, the
Indemnifying Party or Indemnified Party, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent the
action, statement or omission. The amount paid or payable by a party as a result
of any Losses is deemed to include, subject to the limitations set out in this
Agreement, any reasonable attorneys’ or other reasonable fees or expenses
incurred by the party in connection with any Proceeding to the extent that
the
party would have been indemnified for the fees or expenses if the
indemnification provided for in this Section 5
was
available to the party.
The
parties agree that it would not be just and equitable if contribution pursuant
to this Section 5(c)
were
determined by pro rata allocation or by any other method of allocation that
does
not take into account the equitable considerations referred to in the
immediately preceding paragraph. The indemnity and contribution agreements
contained in this Section are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.
4
6. Miscellaneous
(a) Remedies.
If the
Company or a Holder breaches any of its obligations under this Agreement, each
Holder or the Company, as the case may be, in addition to being entitled to
exercise all rights granted by law and under this Agreement, is entitled to
specific performance of its rights under this Agreement.
(b) Compliance.
Each
Holder will comply with the prospectus delivery requirements of the Securities
Act as applicable to it in connection with sales of Registrable Securities
pursuant to the Registration Statement.
(c) Discontinued
Disposition.
Each
Holder will, when it receives a notice from the Company under Section
3(f),
immediately stop selling the Registrable Securities under the Registration
Statement until the Holder has received written notice from the Company that
the
use of the applicable Prospectus may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly
as
is practicable.
(d) Amendments
and Waivers.
This
Agreement may not be amended, modified or supplemented, and waivers or consents
to departures from its provisions may not be given, unless they are written
and
signed by the Company and each Holder of the then outstanding Registrable
Securities.
(e) Notices.
Any
notices or other communications or deliveries required or permitted to be
provided hereunder must be made in accordance with the provisions of the
Purchase Agreement.
(f) Successors
and Assigns.
This
Agreement inures to the benefit of and binds the successors and permitted
assigns of each of the parties and inures to the benefit of each
Holder.
(g) Execution
and Counterparts.
This
Agreement may be executed in any number of counterparts and delivered to the
other parties by any means, each of which when so executed is deemed to be
an
original and, all of which taken together will constitute one and the same
Agreement.
(h) Governing
Law.
All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement will be determined with the provisions of the Purchase
Agreement.
(i) Cumulative
Remedies.
The
remedies provided are cumulative and do not exclude any remedies provided by
law.
5
(j) Severability.
If any
term, provision, covenant or restriction of this Agreement is held by a court
of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions remain in full
force and effect and are in no way affected, impaired or invalidated, and the
parties will use their commercially reasonable efforts to find and employ an
alternative means to achieve the same or substantially the same result as that
contemplated by the term, provision, covenant or restriction. The parties
stipulate that they would have executed the remaining terms, provisions,
covenants and restrictions without including any that might be declared invalid,
illegal, void or unenforceable.
(k) Headings.
The
headings in this Agreement are for convenience of reference only and do not
limit or otherwise affect the meaning.
(l) Independent
Nature of Holders’ Obligations and Rights.
The
obligations of each Holder are several and not joint with the obligations of
any
other Holder, and no Holder can be responsible in any way for the performance
of
the obligations of any other Holder. Nothing in the Transaction Documents
delivered at any Closing, and no action taken by any Holder pursuant to them,
can be deemed to constitute the Holders as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Holders are in any way acting in concert with respect to such obligations or
the
transactions contemplated by this Agreement. Each Holder is entitled to protect
and enforce its rights and it is not necessary for any other Holder to be joined
as an additional party in any proceeding for such purpose.
*************************
6
In
witness whereof,
the
parties have executed this Registration Rights Agreement as of the date first
written above.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Xxxxx
X. Xxxx
President
|
7
EXHIBIT
B
Neither
this security nor the securities into which this security is exercisable have
been registered with the Securities and Exchange Commission or the securities
commission of any state in reliance upon an exemption from registration under
the Securities Act of 1933 (the “Securities Act”), and, accordingly, may not be
offered or sold except pursuant to an effective registration statement under
the
Securities Act or pursuant to an available exemption from, or in a transaction
not subject to, the registration requirements of the Securities Act and in
accordance with applicable state securities laws as evidenced by a legal opinion
of counsel to the transferor to such effect, the substance of which will be
reasonably acceptable to the company.
This
security and the securities into which this security is exercisable have been
issued pursuant to an exemption from registration under the Securities Act
of
1933, as amended, pursuant to regulation S thereunder. This security and the
securities into which this security is excercisable cannot be transferred,
offered, or sold in the united states or to U.S. Persons (as that term is
defined in regulation S) except pursuant to registration under the Securities
Act of 1933, or pursuant to an available exemption from
registration.
COMMON
STOCK PURCHASE WARRANT
To
purchase 50,000
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
Feb 3,
2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value
received, Xxxxxx Xxxxxx (“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
50,000 shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated
10/12/2005,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
2
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance
of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/
Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8
EXHIBIT
B
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE
OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION
OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL
BE
REASONABLY ACCEPTABLE TO THE COMPANY.
THIS
SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN
ISSUED PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF
1933, AS AMENDED, PURSUANT TO REGULATION S THEREUNDER. THIS SECURITY AND
THE
SECURITIES INTO WHICH THIS SECURITY IS EXCERCISABLE CANNOT BE TRANSFERRED,
OFFERED, OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS (AS THAT TERM IS
DEFINED IN REGULATION S) EXCEPT PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT OF 1933, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION.
COMMON
STOCK PURCHASE WARRANT
To
purchase 16,667
shares
of common stock of
BULLION
RIVER GOLD CORP.
Dated:
January
23, 2006
This
common stock purchase warrant
(the
“Warrant”)
certifies that, for value received, Xxxxxx Xxxxxx
(“the
“Holder”),
is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date given above
(the “Initial
Exercise Date”)
and by
the close of business on the second anniversary of the Initial Exercise Date
(the “Termination
Date”)
but
not thereafter, to subscribe for and purchase from Bullion River Gold Corp.,
a
Nevada corporation (the “Company”),
up
to
16,667
shares
(the “Warrant
Shares”)
of
common stock, par value $0.001 per share, of the Company (the “Common
Stock”).
The
purchase price of one share of Common Stock under this Warrant is equal to
the
Exercise Price, as defined in Section 2(a).
1. Definitions.
Capitalized terms used and not otherwise defined in this Warrant have the same
meanings as they have in the Securities Purchase Agreement (the “Purchase
Agreement”),
dated 11/16/2004,
among
the Company and the Holder as Purchaser.
1
2. Exercise.
(a) Exercise
Price.
The
exercise price of the Common Stock under this Warrant is $0.75,
(b) Exercise
of Warrant.
The
Holder may exercise the purchase rights represented by this Warrant at any
time
from the Initial Exercise Date to five o’clock in the afternoon, Reno time, on
the Termination Date by delivering to the Company (i) a duly executed facsimile
copy of the annexed Notice of Exercise, and, (ii) within 5 Trading Days of
delivering the Notice of Exercise to the Company, (A) this Warrant, and (B)
by
wire or cashier’s check drawn on a United States bank the United States dollar
amount equal to the number of Warrant Shares being purchased times the Exercise
Price (the “Exercise
Amount”).
(c) Exercise
limitations.
(i) The
Holder may not exercise any portion of this Warrant if, immediately after the
Warrant Shares are issued, the Holder (together with the Holder’s Affiliates)
would beneficially own more than 4.99% of the number of shares of the Common
Stock outstanding. For the purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates
includes the number of shares of Common Stock issuable upon the exercise of
this
Warrant, but excludes the number of shares of Common Stock that would be
issuable upon (i) the Holder’s exercise of the remaining, unexercised portion of
this Warrant and (ii) the Holder’s or its Affiliates’ exercise or conversion of
the unexercised or nonconverted portion of any other securities of the Company
that the Holder or any of its Affiliates own beneficially.
Except as set forth in the foregoing sentence, for the purposes of this Section
2(c),
beneficial ownership must be calculated in accordance with Section 13(d) of
the
Securities and Exchange Act of 1934 (“Exchange
Act”).
(ii) The
Holder acknowledges that the Company is not representing to Holder that the
calculation described in Section 2(c)(i)
complies
with Section 13(d) of the Exchange Act and Holder is solely responsible for
any
schedules required to be filed in accordance with it. The determination of
whether this Warrant is exercisable (in relation to other securities owned
by
the Holder and its Affiliates) is in the sole discretion of the Holder, and
the
submission of a Notice of Exercise is deemed to be the Holder’s declaration that
the Holder has determined that this Warrant is exercisable as set out in the
Notice of Exercise and subject to the limitations in this Section 2(c);
and the
Company is not obliged to verify or confirm the accuracy of the Holder’s
determination.
2
(iii) For
the
purposes of this Section 2(c),
in
determining the number of outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common Stock as reflected in the
most recent of (A) the latest filed of the Company’s Form 10-QSB and Form
10-KSB, (B) a public announcement by the Company stating the number of shares
of
Common Stock outstanding, or (C) any other notice by the Company or the
Company’s Transfer Agent stating the number of shares of Common Stock
outstanding. If Holder asks for it, the Company will within two Trading
Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding.
(d) Mechanics
of Exercise.
(i) Authorization
of Warrant Shares.
The
Company will issue all Warrant Shares as duly authorized, validly issued, fully
paid and non-assessable, and free from all taxes, liens and charges (other
than
taxes in respect of any transfer occurring contemporaneously with the issue).
(ii) Delivery
of certificates upon exercise.
The
Company’s transfer agent will deliver certificates for Warrant Shares to the
Holder to the address specified by the Holder in the Notice of Exercise within
3
Trading Days from the later of (A) the Company’s receipt of the Notice of
Exercise, (B) the Holder’s surrender of this Warrant, and (C) the Company’s
receipt of the Exercise Amount as set out in Section 2(b)
(“Warrant
Share Delivery Date”).
This
Warrant is deemed to have been exercised on the date the Exercise Amount is
received by the Company (“Exercise
Date”);
and
the Warrant Shares are deemed to have been issued, and Holder is deemed to
have
become a holder of record of the shares for all purposes, on the Exercise
Date.
(iii)
Delivery
of new Warrants upon exercise.
If this
Warrant is exercised in part, the Company will, when it delivers the certificate
or certificates representing Warrant Shares, deliver to Holder a new Warrant
evidencing the rights of Holder to purchase the unpurchased Warrant Shares,
identical in all other respects with this Warrant.
(iv)
Rescission
rights.
If the
Company fails to cause its transfer agent to transmit to the Holder a
certificate or certificates representing the Warrant Shares pursuant to this
Section 2(d)(iv)
by the
Warrant Share Delivery Date, then the Holder may rescind the
exercise.
(v)
No
fractional shares or scrip.
No
fractional shares or scrip representing fractional shares may be issued upon
the
exercise of this Warrant. If the Holder would otherwise be entitled to
fractional shares upon the exercise, the Company will pay a cash adjustment
in
respect of the fraction in an amount equal to the fraction multiplied by the
Exercise Price.
(vi)
Charges,
taxes and expenses.
The
Company will issue certificates for Warrant Shares in the name of the Holder
and
will not charge the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of the certificate.
(vii)
Closing
of books.
The
Company will not close its stockholder books or records in any manner that
prevents the timely exercise of this Warrant.
3
3. Certain
Adjustments.
(a) Stock
dividends and splits.
If the
Company, at any time while this Warrant is outstanding,
(i)
pays a stock dividend or otherwise makes a distribution on shares of its Common
Stock or any other Common Stock Equivalent (which, for avoidance of doubt,
does
not include any shares of Common Stock issued by the Company pursuant to this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger
number of shares, (iii) combines outstanding shares of Common Stock into a
smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then the Exercise
Price
must be multiplied by a fraction of which the numerator is the number of shares
of Common Stock (excluding treasury shares, if any) outstanding before the
event
and of which the denominator is the number of shares of Common Stock outstanding
after the event, and the number of shares issuable upon exercise of this Warrant
must be proportionately adjusted by this fraction. Any adjustment made pursuant
to this Section 3(a)
is
effective immediately after the record date for the determination of
stockholders entitled to receive the dividend or distribution and is effective
immediately after the effective date in the case of a subdivision, combination
or re-classification.
(b) Fundamental
Transaction.
If, at
any time while this Warrant is outstanding,
(i) the
Company merges or consolidates with or into another Person, (ii) the Company
sells all or substantially all of its assets in one or a series of related
transactions, (iii) any Person completes a tender offer or exchange offer by
which holders of Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (iv) the Company reclassifies its
Common Stock or completes any compulsory share exchange pursuant to which the
Common Stock is effectively converted into or exchanged for other securities,
cash or property (in any such case, a “Fundamental
Transaction”),
then,
upon any subsequent conversion of this Warrant, the Holder has the right to
receive, for each Warrant Share that would have been issued upon the exercise
absent the Fundamental Transaction, the same consideration as the Company has
given its other holders of its Common Stock for the conversion of their Common
Stock outstanding at the time of the Fundamental Transaction (the “Alternate
Consideration”).
Any
successor to the Company or surviving entity in a Fundamental Transaction must
issue to the Holder a new warrant consistent with the foregoing provisions
with
evidence of the Holder’s right to exercise the warrant into Alternate
Consideration. The terms of any agreement pursuant to which a Fundamental
Transaction is completed must include terms requiring the successor or surviving
entity to comply with the provisions of this Section 3(b)
and
insuring that this Warrant (or any replacement security) is similarly adjusted
upon any subsequent transaction analogous to a Fundamental
Transaction.
(c) Calculations.
All
calculations under this Section 3
must be
made to the nearest cent or the nearest 1/100th
of a
share, as the case may be. The number of shares of Common Stock outstanding
at
any given time does not include shares of Common Stock owned or held by or
for
the account of the Company. For the purposes of this Section 3,
the
number of shares of Common Stock deemed to be issued and outstanding as of
a
given date is the sum of the number of shares of Common Stock (excluding
treasury shares, if any) issued and outstanding.
4
(d) Notice
to Holders.
If the
Company makes adjustments under this Section 3,
the
Company will promptly mail to each Holder a notice containing a description
of
the event that required the adjustment. If the Company proposes any transaction
that affects the rights of the holders of its Common Stock, then the Company
will notify the Holders of the proposal at least twenty days before the record
date set for the transaction.
4. Warrant
register.
The
Company will register this Warrant on its warrant register and will treat the
registered Holder as the absolute owner for all purposes.
5. Miscellaneous.
(a) Title
to Warrant.
This
Warrant is not transferable.
(b) No
rights as shareholder until Exercise Date.
This
Warrant does not entitle the Holder to any voting rights or other rights as
a
shareholder of the Company before the Exercise Date. Upon the surrender of
this
Warrant and the payment of the aggregate Exercise Price, the Company will issue
the Warrant Shares to the Holder as the record owner of the Warrant Shares
as of
the close of business on the Exercise Date.
(c) Loss,
Theft, Destruction or Mutilation of Warrant.
The
Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Warrant Shares, and, in case of loss,
theft or destruction, of indemnity or security reasonably satisfactory to it,
and upon surrender and cancellation of the Warrant or stock certificate, if
mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of the cancellation, in lieu of the Warrant or stock
certificate.
(d) Saturdays,
Sundays, Holidays, etc.
If the
last date for doing anything under this Warrant falls on a Saturday, Sunday
or a
legal holiday, then the thing may be done on the next succeeding Trading
Day.
(e) Authorized
Shares.
(i) The
Company covenants that, while the Warrant is outstanding, it will reserve from
its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of
this Warrant constitutes full authority to its officers who are charged with
the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may
be
necessary to assure that the Warrant Shares are issued as provided without
a
violation of any applicable law or regulation, or of any requirements of the
Trading Market upon which the Common Stock may be listed or quoted.
5
(ii)
Unless
waived or consented to by the Holder, the Company will not by any action avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in carrying out of all
its
terms and take whatever actions is necessary or appropriate to protect the
rights of Holder under this Warrant from impairment.
(f) Jurisdiction.
All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant must be determined in accordance with the provisions of the
Purchase Agreement.
(g) Restrictions.
The
Holder acknowledges that the Holder’s sale or transfer of the Warrant Shares, if
not registered, will be subject to restrictions upon resale imposed by state
and
federal securities laws.
(h) No
waiver.
No
course of dealing or any delay or failure to exercise any right hereunder on
the
part of Holder operates as a waiver of the right or otherwise prejudices
Holder’s rights, powers or remedies.
(i) Notice.
Any
notice, request or other document required or permitted to be given or delivered
by either party to the other must be delivered in accordance with the notice
provisions of the Purchase Agreement.
(j) Successors
and Assigns.
Subject
to applicable securities laws, this Warrant inures to the benefit of and binds
the successors and permitted assigns of the Company and the Holder.
(k) Amendment.
Any
amendment of this Warrant must be in writing and signed by both the Company
and
the Holder.
(l) Severability.
Wherever possible, each provision of this Warrant must be interpreted under
applicable law, but if any provision of this Warrant is prohibited by or invalid
under applicable law, the provision is ineffective to the extent of the
prohibition or invalidity, without invalidating the remaining provisions of
this
Warrant.
(m) Headings.
The
headings used in this Warrant are for the convenience of reference only and
are
not, for any purpose, deemed a part of this Warrant.
6
In
witness whereof
the
Company has caused this Warrant to be executed by its duly authorized
officer.
BULLION
RIVER GOLD CORP.
|
|
By:
/s/ Xxxxx X. Xxxx
Name:
Xxxxx X. Xxxx
Title:
President
|
7
NOTICE
OF EXERCISE
To: Bullion
River Gold Corp.
The
undersigned hereby elects to purchase _____________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only
if
exercised in full; if exercised in part, attach a copy of the Warrant), and
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.
Payment
will take the form of lawful money of United States.
Please
deliver the Warrant Shares to the following:
________________________________________
________________________________________
________________________________________
________________________________________________
Signature
of Holder or authorized signatory of Holder
Name
of
Holder: _______________________________________________________
Name
of
authorized signatory: ____________________________________________
Title
of
authorized signatory: _____________________________________________
Date:
_____________________________
8